quality of care

Research in Review

PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer

05/12/2017

JCP Editors

New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...

New...

05/12/2017

Journal of Clinical Pathways

Research in Review

Christiana Care Health System Pioneers Clinical Pathways in the Tri-State Area

05/09/2017

JCP Editors

The Christiana Care Health System provides a model for successfully implementing clinical pathways across a wide range of diseases and stages. Within the mid-Atlantic region of the US, the Christiana Care Health...

The...

05/09/2017

Journal of Clinical Pathways

Research in Review

Patients With NSCLC Treated With Immunotherapy Likely to Respond to Chemo

05/09/2017

JCP Editors

Patients with advanced non-small cell lung cancer (NSCLC) who undergo salvage chemotherapy are 30% more likely to achieve partial response if they have been treated with a PD-1/PD-L1 checkpoint inhibitor, according...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment

05/04/2017

JCP Editors

MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...

MRI...

05/04/2017

Journal of Clinical Pathways

Research in Review

Flu Vaccine May Cause Adverse Events for Lung Cancer Patients on Immunotherapy

05/03/2017

JCP Editors

Patients with lung cancer who are treated with immunotherapy may be at increased risk of severe adverse events after receiving the seasonal influenza vaccination, according to results of a study presented at the...

...

05/03/2017

Journal of Clinical Pathways

Research in Review

CAR T-Cells Offer Biomarker for Objective Response in Non-Hodgkin Lymphoma

04/28/2017

JCP Editors

The ability of chimeric antigen receptor (CAR) T-cells to perform multiple functions is associated with improved outcomes for patients with advanced non-Hodgkin lymphoma, offering a biomarker for response, according...

The...

04/28/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma

04/27/2017

JCP Editors

Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...

...

04/27/2017

Journal of Clinical Pathways

Research in Review

Dose-Escalated Therapy May Be Curative for Multiple B-Cell Malignancies

04/26/2017

JCP Editors

Dose-escalated therapy involving a single agent produced complete and partial responses in patients with different B-cell malignancies. ----- Related Content Maintenance Therapy Effective in Treating Diffuse Large...

...

04/26/2017

Journal of Clinical Pathways

Research in Review

Bone Model Examines Treatment Effectiveness for Breast Cancer Metastases

04/24/2017

JCP Editors

A bone metastasis model has been created that simulates interactions between metastatic breast cancer cells and bone cells to determine effectiveness of different treatments, published in Nature Communications...

A bone...

04/24/2017

Journal of Clinical Pathways

Research in Review

Palbociclib Plus Fulvestrant Improves PFS in Type of Breast Cancer

04/19/2017

JCP Editors

Adding palbociclib to fulvestrant prolongs progression-free survival (PFS) compared with fulvestrant alone among pre- and post-menopausal women with hormone receptor (HR)-positive, human epidermal growth factor...

Adding...

04/19/2017

Journal of Clinical Pathways